Background Activating mutation of KIT or PDGFRA is the primary molecular mechanism for gastrointestinal stromal tumors (GISTs). Although imatinib has ......
Liu, WZ; Zeng, XY; Yin, YP; Li, CG; Yang, WC; Wan, WZ; Shi, L; Wang, GB; Tao, KX; Zhang, P
Zhang, P (corresponding author), Huazhong Univ Sci & Technol, Dept Gastrointestinal Surg, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China.
GASTRIC CANCER, 2020; 23 (1): 39